E
TRDA
Entrada Therapeutics, Inc.
6.46
+0.15+2.38%Opening15:01 05/22 EDT
OPEN/PREV CLOSE6.51/6.31
TODAY RANGE6.44-6.76
VOL227.25K
MARKET CAP250.78M
52 WEEK RANGE4.930-16.45
AVG VOL (3M)350.77K
% TURNOVER0.59%
TURNOVER--
P/E (TTM)-1.6159
% RANGE5.07%
EPS(TTM)-3.9977
P/E(FORWARD)-1.5236
P/B0.9259
BVPS6.98
DIVIDEND--
P/S9.73
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP214.99M
SHARES OUTSTANDING38.82M
NEXT EARNINGS08/04-08/10
FREE FLOAT33.28M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/08 19:22
Entrada Therapeutics price target lowered to $10 from $19 at Roth Capital
Benzinga·05/08 12:28
This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Dow Jones·05/08 12:08
Entrada Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Benzinga·05/08 11:57
HC Wainwright & Co. Downgrades Entrada Therapeutics to Neutral
TipRanks·05/08 10:33
Entrada Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Dow Jones·05/07 23:20
Entrada Therapeutics Declines on Duchenne Muscular Dystrophy Study Data -- Update
TipRanks·05/07 18:55
Entrada Therapeutics reports topline data from Cohort 1 of ELEVATE-44-201 study
Dow Jones·05/07 18:00
Entrada Therapeutics Shares Decline on Duchenne Muscular Dystrophy Study Data
Reuters·05/07 17:50
BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Benzinga·05/07 17:39
Dow Dips 350 Points; US Foods Posts Downbeat Earnings
Same Industry
Name/Symbol
Change%
Price